Publication:
Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology

dc.contributor.departmentDepartment of Molecular Biology and Genetics
dc.contributor.departmentGraduate School of Sciences and Engineering
dc.contributor.kuauthorKır, Serkan
dc.contributor.kuauthorÖzen, Sevgi Döndü
dc.contributor.schoolcollegeinstituteCollege of Sciences
dc.contributor.schoolcollegeinstituteGRADUATE SCHOOL OF SCIENCES AND ENGINEERING
dc.date.accessioned2024-12-29T09:39:55Z
dc.date.issued2024
dc.description.abstractSkeletal muscle is essential in generating mechanical force and regulating energy metabolism and body temperature. Pathologies associated with muscle tissue often lead to impaired physical activity and imbalanced metabolism. Recently, ectodysplasin A2 receptor (EDA2R) signaling has been shown to promote muscle loss and glucose intolerance. Upregulated EDA2R expression in muscle tissue was associated with aging, denervation, cancer cachexia, and muscular dystrophies. Here, we describe the roles of EDA2R signaling in muscle pathophysiology, including muscle atrophy, insulin resistance, and aging-related sarcopenia. We also discuss the EDA2R pathway, which involves EDA-A2 as the ligand and nuclear factor (NF)κB-inducing kinase (NIK) as a downstream mediator, and the therapeutic potential of targeting these proteins in the treatment of muscle wasting and metabolic dysfunction. © 2024 Elsevier Ltd
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue5
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuTÜBİTAK
dc.description.sponsorshipThis work was supported by the European Molecular Biology Organization (EMBO) installation grant (# 4162 ) and the Scientific and Technological Research Council of Turkiye (TUBITAK) grants ( 118Z167 , 122Z163 ) to S. Kir.
dc.description.volume30
dc.identifier.doi10.1016/j.molmed.2024.02.002
dc.identifier.eissn1471-499X
dc.identifier.issn1471-4914
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85186663470
dc.identifier.urihttps://doi.org/10.1016/j.molmed.2024.02.002
dc.identifier.urihttps://hdl.handle.net/20.500.14288/23164
dc.identifier.wos1240297900001
dc.keywordsAging-related sarcopenia
dc.keywordsEctodysplasin A2 receptor signaling
dc.keywordsInsulin resistance in muscle
dc.keywordsNFκB-inducing kinase
dc.keywordsSkeletal muscle atrophy
dc.language.isoeng
dc.publisherElsevier Ltd
dc.relation.grantnoEuropean Molecular Biology Organization, EMBO, (4162)
dc.relation.grantnoTürkiye Bilimsel ve Teknolojik Araştırma Kurumu, TÜBİTAK, (118Z167, 122Z163)
dc.relation.ispartofTrends in Molecular Medicine
dc.subjectBiochemistry and molecular biology
dc.subjectCell biology
dc.subjectMedicine, research and experimental
dc.titleEctodysplasin A2 receptor signaling in skeletal muscle pathophysiology
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorÖzen, Sevgi Döndü
local.contributor.kuauthorKır, Serkan
local.publication.orgunit1College of Sciences
local.publication.orgunit1GRADUATE SCHOOL OF SCIENCES AND ENGINEERING
local.publication.orgunit2Department of Molecular Biology and Genetics
local.publication.orgunit2Graduate School of Sciences and Engineering
relation.isOrgUnitOfPublicationaee2d329-aabe-4b58-ba67-09dbf8575547
relation.isOrgUnitOfPublication3fc31c89-e803-4eb1-af6b-6258bc42c3d8
relation.isOrgUnitOfPublication.latestForDiscoveryaee2d329-aabe-4b58-ba67-09dbf8575547
relation.isParentOrgUnitOfPublicationaf0395b0-7219-4165-a909-7016fa30932d
relation.isParentOrgUnitOfPublication434c9663-2b11-4e66-9399-c863e2ebae43
relation.isParentOrgUnitOfPublication.latestForDiscoveryaf0395b0-7219-4165-a909-7016fa30932d

Files